Quinazolin-4-ylamine
| Title | Journal |
|---|---|
| Synthesis and evaluation of novel F-18 labeled 4-aminoquinazoline derivatives: potential PET imaging agents for tumor detection. | Bioorganic & medicinal chemistry letters 20120715 |
| (E)-2-[2-(4-Chloro-benzyl-idene)hydrazin-1-yl]-4-{[3-(dimethyl-aza-nium-yl)prop-yl]amino}-quinazolin-1-ium bis-(perchlorate). | Acta crystallographica. Section E, Structure reports online 20120501 |
| Design, synthesis and antitumor activity of 4-aminoquinazoline derivatives targeting VEGFR-2 tyrosine kinase. | Bioorganic & medicinal chemistry letters 20120101 |
| Investigation of a novel molecular descriptor for the lead optimization of 4-aminoquinazolines as vascular endothelial growth factor receptor-2 inhibitors: application for quantitative structure-activity relationship analysis in lead optimization. | Bioorganic & medicinal chemistry letters 20110301 |
| Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors. | Bioorganic & medicinal chemistry letters 20110101 |
| Prediction of inhibitory activity of epidermal growth factor receptor inhibitors using grid search-projection pursuit regression method. | PloS one 20110101 |
| Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells. | BMC cancer 20110101 |
| Discovery and structure-activity relationships of 4-aminoquinazoline derivatives, a novel class of opioid receptor like-1 (ORL1) antagonists. | Bioorganic & medicinal chemistry 20090101 |
| Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase. | Bioorganic & medicinal chemistry 20080815 |
| ThermoTRP channels in nociceptors: taking a lead from capsaicin receptor TRPV1. | Current neuropharmacology 20080301 |
| Synthesis and bioactivities of 6,7,8-trimethoxy-N-aryl-4-aminoquinazoline derivatives. | Bioorganic & medicinal chemistry 20071015 |
| The novel Src kinase inhibitor M475271 inhibits VEGF-induced vascular endothelial-cadherin and beta-catenin phosphorylation but increases their association. | Journal of pharmacological sciences 20060901 |
| Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts. | Molecular cancer therapeutics 20060801 |
| Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients. | Cancer investigation 20060101 |
| A novel Src kinase inhibitor, M475271, inhibits VEGF-induced human umbilical vein endothelial cell proliferation and migration. | Journal of pharmacological sciences 20050601 |
| SRC tyrosine kinase inhibitor, m475271, suppresses subcutaneous growth and production of lung metastasis via inhibition of proliferation, invasion, and vascularization of human lung adenocarcinoma cells. | Clinical & experimental metastasis 20050101 |
| Efficient synthesis of 4-aminoquinazoline and thieno[3,2-d]pyrimidin-4-ylamine derivatives by microwave irradiation. | Organic letters 20041209 |
| A new synthetic approach of N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide (JTC-801) and its analogues and their pharmacological evaluation as nociceptin receptor (NOP) antagonists. | European journal of medicinal chemistry 20041201 |
| Synthesis and alpha 1-adrenoceptor antagonistic activity of some 4-amino-5,7-dimethyl-2-(substituted) aminopyrido (2,3-d) pyrimidines. | Arzneimittel-Forschung 20020101 |